(RICHMOND) –Advanced Cyclotron Solutions Inc. (ACSI) is applauding a federal expert panel’s recommendation that lists cyclotrons as a key option to solve Canada’s medical isotope shortage.
“We are extremely excited to receive a positive recommendation for a cyclotron option to solve this shortage, and look forward to working with the federal government on this solution,” says ACSI CEO and President Richard Eppich.
Natural Resources Canada today released the report of the Expert Review Panel on Medical Isotope Production. Their second recommendation was “that the cyclotron option for direct production of Tc-99m, which has many attractive features, be explored further.”
In their submission to the panel, ACSI proposed to collaborate with 5 Canadian universities and research centres to establish a National Cyclotron Network. With a one-time capital investment of 52.5 million, they say this Network would be able to solve Canada’s current medical isotope shortage with no need for annual federal subsidies.
“From the technology to the manufacturing, processing and distribution, the National Cyclotron Network is a true “Made in Canada” solution to the medical isotope shortage,” says Eppich. “Along with the substantial economic benefits, this technology is nuclear waste free and does not use weapons-grade uranium.”
ACSI proposes to use its’ new TR-24 cyclotron to produce technetium-99m, the medical isotope which has been in short supply since the Chalk River reactor shutdown earlier this year. Technetium-99m is a critical medical isotope, and is used to detect cancer, heart disease and kidney malfunction.
“Cyclotrons already supply the majority of medical radioisotopes other than technetium-99 that are used in medical practice. I believe that cyclotron technology may offer an optimum solution to the worldwide isotope shortage, while allowing the development of a new business model for the provision of medical isotopes,” says Dr. Sandy McEwan, Chair, Department of Oncology at the University of Alberta.
In their report, the Expert Panel called for support for an R&D program to further explore the cyclotron option.
“We look forward to working with the federal government on this option,” concludes Eppich. “We believe our proposed model will position Canada at the forefront of nuclear medicine and will provide long-term benefits for both the Canadian economy and our health care system.”
FOR MORE INFORMATION: Marcella Munro, Cel 604-345-3214 or email@example.com
Email to a Friend:
Return to: Main Blog